<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Denichenko P</dc:creator>
  <dc:creator>Mogilevsky M</dc:creator>
  <dc:creator>Cléry A</dc:creator>
  <dc:creator>Welte T</dc:creator>
  <dc:creator>Biran J</dc:creator>
  <dc:creator>Shimshon O</dc:creator>
  <dc:creator>Barnabas GD</dc:creator>
  <dc:creator>Danan-Gotthold M</dc:creator>
  <dc:creator>Kumar S</dc:creator>
  <dc:creator>Yavin E</dc:creator>
  <dc:creator>Levanon EY</dc:creator>
  <dc:creator>Allain FH</dc:creator>
  <dc:creator>Geiger T</dc:creator>
  <dc:creator>Levkowitz G</dc:creator>
  <dc:creator>Karni R</dc:creator>
  <dc:date>2019</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Alternative splicing, a fundamental step in gene expression, is deregulated in many diseases. Splicing factors (SFs), which regulate this process, are up- or down regulated or mutated in several diseases including cancer. To date, there are no inhibitors that directly inhibit the activity of SFs. We designed decoy oligonucleotides, composed of several repeats of a RNA motif, which is recognized by a single SF. Here we show that decoy oligonucleotides targeting splicing factors RBFOX1/2, SRSF1 and PTBP1, can specifically bind to their respective SFs and inhibit their splicing and biological activities both in vitro and in vivo. These decoy oligonucleotides present an approach to specifically downregulate SF activity in conditions where SFs are either up-regulated or hyperactive.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://sonar.ch/global/documents/188393</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1038/s41467-019-09523-0</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/30962446</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:source>Nature communications. - 2019</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Alternative Splicing</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Animals</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Animals, Genetically Modified</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Binding Sites</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Glioblastoma</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">HEK293 Cells</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Heterogeneous-Nuclear Ribonucleoproteins</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">MAP Kinase Signaling System</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Muscle, Skeletal</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Nonsense Mediated mRNA Decay</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Oligonucleotides</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Polypyrimidine Tract-Binding Protein</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">RNA Splicing Factors</dc:subject>
  <dc:subject xmlns:ns15="xml" ns15:lang="en">Serine-Arginine Splicing Factors</dc:subject>
  <dc:subject xmlns:ns16="xml" ns16:lang="en">Tandem Repeat Sequences</dc:subject>
  <dc:subject xmlns:ns17="xml" ns17:lang="en">Xenograft Model Antitumor Assays</dc:subject>
  <dc:subject xmlns:ns18="xml" ns18:lang="en">Zebrafish</dc:subject>
  <dc:title xmlns:ns19="xml" ns19:lang="en">Specific inhibition of splicing factor activity by decoy RNA oligonucleotides.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
